Pharmaceutical manufacturers of Clotrimazole

OLON Group is a prominent worldwide firm specializing in the creation and manufacture of active pharmaceutical ingredients for CDMO and Generics. It serves as a dependable and preferred partner for the pharmaceutical, biotech, and specialty ingredients sectors. With a 2021 turnover of 580 million dollars, OLON provides 300 APIs for the Generic market. The company benefits from a workforce of 2,300 employees, including a highly skilled R&D team of over 300 individuals. This enables OLON to offer comprehensive integrated packages and services to facilitate the full development of APIs, leveraging extensive expertise in both Chemical and Biological processes, all within a full cGMP and regulatory framework. OLON holds approximately 160 active US DMFs and 79 granted CoS. OLON's headquarters is located in Rodano, near Milan, Italy, and it operates 11 manufacturing facilities - 8 in Italy, 1 in Spain, 1 in the USA, and 1 in India. These facilities are designed in accordance with the most stringent international standards. Additionally, OLON has 3 branch offices in Hamburg (Germany), Florham Park, NJ (USA), and Shanghai (China).

CordenPharma International, an all-encompassing CDMO for the worldwide market. Established as the global pharmaceutical service & production platform of International Chemical Investors Group in 2006, CordenPharma serves as your all-encompassing ally in the Contract Development & Manufacturing (CDMO) of APIs, Drug Products, and associated Packaging Services. With an expanding network of cGMP facilities throughout Europe and the US structured under five Technology Platforms – Peptides, Lipids & Carbohydrates - Highly Potent & Oncology - Injectables - Small Molecules - Antibiotics – CordenPharma specialists interpret intricate processes, concepts and ventures at any phase.

Sanofi is a global healthcare leader committed to improving lives around the world. With a strong focus on research and development, Sanofi strives to transform scientific innovation into healthcare solutions that address unmet medical needs. The company's extensive portfolio spans prescription medicines, vaccines, consumer healthcare products, and biopharmaceuticals, covering a wide range of therapeutic areas, including diabetes, cardiovascular disease, oncology, immunology, rare diseases, and vaccines.

Amoli has been working collaboratively with some of the leading global healthcare players since 3 decades. Our strength comes from our expertise in process chemistry further bolstered by our EDQM and USFDA approved facilities allowing us to cater to the needs of the pharmaceutical industry globally. We offer APIs from a wide range of therapeutic classes like NSAIDS, Antifungals, Antidepressants, Hypolipidemics etc. With the support our state-of-the-art R&D centre, we are constantly expanding our product range and foraying into newer therapeutic categories.

Fisvi is a distinguished Italian company with a proud heritage in the manufacturing and innovation sectors. Specializing in advanced materials and cutting-edge solutions, Fisvi offers a wide range of products tailored to meet the demands of various industries, including construction, automotive, and industrial applications. Their product lineup includes high-quality insulation materials, adhesives, sealants, and other specialized components designed to enhance performance and durability.

Erregierre, with its two manufacturing facilities, one situated in San Paolo D'Argon (Bergamo) and the other in Sovere (Bergamo), is a privately owned independent company from Italy established in 1974. It is a leading producer of pharmaceutical active components created through synthesis and distributed globally. Erregierre has undergone inspection by the FDA and is deeply dedicated to manufacturing in strict compliance with cGMPs and the highest global quality standards.

We, at TIEFENBACHER GROUP, are driven by a deep sense of purpose: we are pioneering healthcare to improve patients’ lives around the world. We believe that the access to affordable high quality-healthcare is a human right. We always challenge the status quo to be one step ahead – in terms of business models as well as concrete products and services. This entrepreneurial spirit is the driving force of making high-quality pharmaceuticals more affordable, more available, and better than before. 100% family owned since 1963, we are a purpose-driven healthcare company providing best-in-class solutions throughout the entire pharmaceutical value chain. From initial idea to market access: We distribute raw materials and develop, manufacture, and register finished dosage forms like tablets, capsules, powders, drops, and patches as well as medical devices. This broad competence enables us to pioneer healthcare holistically as we can connect ideas and expertise to create novel healthcare solutions. By working together as TIEFENBACHER GROUP, in agile collaboration and cross-functional structures, we tap into our full potential and stay at the forefront of our field.

Midas Care Pharmaceuticals brings extensive expertise and skill in the Aerosol Industry dating back to 1986. We were pioneers in aerosol production in India and have established our footprint in 72 nations. Our diverse range of products spans categories such as MDI, Respiratory, Aerosols, OTC, Medical devices, and more. Our additional certifications include USFDA, Health Canada, TGA, UK-MHRA, PIC/S, MOH Russia, WHO GMP, ISO 13485:2018, ISO 22716:2007, and numerous others.

Biesterfeld Spezialchemie stands as a prominent global distributor of specialty chemical products, pharmaceuticals, and food ingredients. The organization provides comprehensive industry expertise and custom, application-oriented technical guidance across a varied product range focusing on the needs of specific sectors, such as composites and tooling, personal care and hygiene, healthcare, paints and coatings, adhesives, polyurethane, construction, nutrition, nutraceuticals, and electrical, electronic, and energy.

An Integrated pharma company with business presence in over 21 countries As a leading global security company we are committed to being at the forefront of technology and innovation, delivering superior capability in tandem with maximized cost efficiencies. This includes our markets around the world where we continue to expand our international presence, strengthen our international partnerships and broaden our focus to one that is increasingly global.

Suppositories, balms, lotions, and ointments are produced through outsourcing in compliance with the relevant GMP criteria. Moreover, RubiePharm provides an extensive array of solutions for the pharmaceutical sector – ranging from the assessment of the quality of the substances utilized to the examination of the final goods.

Established in 2003, Jiangsu Yuanyang Pharmaceutical Co., Ltd. (referred to as Yuanyang Pharma hereafter, formerly known as Changshu Jincheng Chem Co.,Ltd and Jiangsu Yuanyang Chemical Co., Ltd.) is situated in Zhitang Industrial Park in the city of Changshu, Jiangsu Province, China. It is located 58 kilometers east of Shanghai and 50 kilometers north of Suzhou, with the nearest state highway being 948.5 kilometers away (G204). Yuanyang Pharma is strategically positioned with easy access to the Changshu-Taizhou expressway, the Yanjiang (along the Yangtze) expressway, the Changshu-Jiaxing expressway, and the Wuxi-Taicang expressway, as well as the ports of Shanghai, Taicang, Changshu, and Zhangjiagang, providing excellent transportation links by road, water, or air.